A clinical Trial to study the effect of two formulation application in Androgenic Alopecia
Phase 2
- Conditions
- Health Condition 1: L648- Other androgenic alopecia
- Registration Number
- CTRI/2023/09/057266
- Lead Sponsor
- VINITA HIREBEE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients presenting with clinical features of androgenic alopecia (Khalitya)
Exclusion Criteria
1) Patients with Alopecia Totalis, Alopecia areata, Alopecia universalis.
2) Patients with Arunshika, Indralupta, Darunaka.
3) Alopecia due to other scalp disorders like Tinea capitis, Trichotillomania, Tillogen effluvium
and Traumatic alopecia.
4) Patients suffering from other systemic disorders, which may affect the study adversely.
5) Variation in clotting and bleeding time.
6) Patients with endocrine disorders like ,Diabetes Mellitus,Hypoparathyroidism
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Androgenic AlopeciaTimepoint: 2months
- Secondary Outcome Measures
Name Time Method Hair regrowth <br/ ><br>Hairfall ReductionTimepoint: 2months